Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1983
The therapeutic use of a new potassium-sparing diuretic, amiloride, and a converting enzyme inhibitor, MK-421, in preventing hypokalemia associated with primary and secondary hyperaldosteronismG T Griffing, J C MelbyMetabolism: Clinical and Experimental|April 1, 1989
Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by trilostane, an inhibitor of adrenal steroidogenesisG T Griffing, J C MelbyJournal of Clinical Hypertension|September 1, 1985
The therapeutic effect of a new angiotensin-converting enzyme inhibitor, enalapril maleate, in idiopathic hyperaldosteronismG T Griffing, J C MelbyJournal of Clinical Pharmacology|July 1, 1985
Biphasic plasma aldosterone responses to four single-dose ACTH regimensG T Griffing, H Pratt, J C MelbyThe Journal of Clinical Endocrinology and Metabolism|November 1, 1984
Transitory increment in urinary free 19-nor-deoxycorticosterone after diuretic-induced renin stimulationG T Griffing, T E Wilson, J C MelbyHypertension (Dallas, Tex. : 1979)|May 1, 1985
Unconjugated and conjugated urinary 19-nor-deoxycorticosterone glucosiduronate. Elevated levels in essential hypertensionG T Griffing, T E Wilson, J C MelbyThe Journal of Clinical Endocrinology and Metabolism|December 1, 1990
Alterations in aldosterone secretion and metabolism in low renin hypertensionG T Griffing, T E Wilson, J C MelbyThe American Journal of Medicine|September 1, 1982
Primary empty sella syndrome, ACTH hypersecretion, and normal adrenocortical function. Report of two casesB H Sindler, G T Griffing, J C MelbyThe Journal of Clinical Endocrinology and Metabolism|December 1, 1982
Altered fractional tetrahydroaldosterone excretion during pharmacological blockade and activation of the renin-aldosterone systemG T Griffing, T E Wilson, J C MelbyHypertension (Dallas, Tex. : 1979)|March 1, 1985
Converting-enzyme inhibitor administration lowers urinary free 19-nor-deoxycorticosterone levelsG T Griffing, T E Wilson, J C MelbyPageof 11